Annovis Bio's total assets for Q4 2025 were $21.08B, an increase of 122546.30% from the previous quarter. ANVS total liabilities were $4.23B for the fiscal quarter, a 104799.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.